Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031)

Summary

The tender concerns the supply of a pentavalent DTaP-IPV+Hib vaccine for Finland’s National Immunisation Program. The contract is for one year, with three optional one-year renewals for 2029, 2030 and 2031. The estimated total quantity is 560,000 doses, and the customer may increase or decrease the ordered quantity by up to 20%. The contract will be awarded to one supplier on the basis of the lowest price. The tender must be submitted electronically, and the procurement documents should be checked for the exact participation, compliance and contract performance requirements.